Tankyrases (TANK1 and TANK2) IRAP (Insulin responsive Amino peptidase,
GBR14, and Tab182
The 3'ends of chromosomes are capped with telomere sequences (TTAGGG;
6-26 nucleotides in length) by ribonucleoprotein
telomerase during DNA replication. Telomerase is an unusual
RNA-dependent DNA polymerase that uses and RNA component to specify the
addition of telomere. The telomeric RNA contains a sequence
complementary to TTAGGG. Approx. 4.8 kb of telomeric DNA is lost with
each cell division. Many mammalian cells do not express telomerase
resulting into shortening of telomere with each cell division, and
ultimately causing the chromosomal instability, aging and cell death.
Interesting, most transformed, immortalized or tumor cells continue to
express telomerase. Introduction of telomerase into normal human cells
has been shown to extend normal cell life by ~ 20 doubling.
Poly(ADP-ribose) polymerases (PARPs)
catalyze formation of long, branched chain of poly(ADP-ribose) onto
protein acceptors using NAD+ as a substrate. Poly(ADP)ribosylation is a
transient posttranslational modification that can either enhance or
reduce protein activity. Tankyrase (TRF1
interacting ankyrin-related ADP-ribose polymerase; human 1327 aa,
renamed as TANK1, chromosome 8), a modular protein with homology to
ankyrin and poly(adenosine diphosphate-ribose) polymerase (PARP) has
been cloned and localized to telomere. The N-terminal HPS domain
contains multiple run of histidine, proline, and serine residue
homopolymers. TANK1 has 24 ankyrin repeats in TRF-1 interacting domain
near the N-terminus. The 33-aa ANK repeat motif mediates protein-protein
interactions. The ANK domain is followed another protein interaction
motif called the sterile alpha-module (SAM). The C-terminal region of
TANK1 contains the PARP activity. TANK1 uses its ANK domain to bind TRF1
and its PARP domain to ADP-ribosylate itself and TRF1, and thereby
inhibiting the ability of TRF1 to bind telomere. The homology between
tankyrase and PARPs is limited to catalytic domain. Takyrase-1 is
expressed in many tissues and targeted to various intracellular
compartments. Tanyrase-1, devoid of NLS (nuclear localization signal),
is translocated to telomere (nucleus) through binding of its ANK domain
to TRF1.
More recently a second tankyrase termed
tankyrase-2/TANK2/TNKL, has been cloned and characterized.
TANK2 gene (chromosome 10q23.2) encodes a
~130-kDa, 1166 aa protein with ~83% identity with TANK1. TANK2 has a
unique N-terminus and lacks the HPS domain found in TANk1. TANK2
interacted with TRF1 and displayed APRP activity. It is widely expressed
with more abundant expression in skeletal muscle and placenta. Unlike
TANK1, TANk2 over expression caused rapid cell death.
In addition to regulating the telomere and
nuclear localization, TANKs also resides at the other subcellular
compartments such as nuclear envelope, specifically on cytoplasmic
fibers of nuclear pore complexes. TANk1 is targeted to pericentriolar
domain of centrosomes during mitosis. After mitosis, TANK1 associates
with the golgi as a peripheral membrane protein and implicated in
targeting of GLUT4 vesicles. In the absence of insulin, GLUT4 vesicles
reside in the Golgi and cytoplasm. Upon stimulation by insulin, GLUT4
vesicles undergo exocytosis and translocate to the plasma membrane.
GLUT4 vesicles are characterized by the presence of glucose transporter
4 (GLUT4) and IRAP (Insulin regulated aminopeptidase). The exocytosis of
GLUT4 vesicles is therefore plays an important role in uptake of glucose
through Glut4 and the degradation of various vascoactive hormones by
IRAP. TANKs have been colocalized in GLUT4 vesicles and shown to bind
IRAP via the ANK-repeats.
IRAP (also known as placental leucine
aminopeptidase, PLAP; leucyl cystinyl aminopeptidase, LNPEP;
oxytocinase, Otase; vesicle protein of 165 kDa or vp165) belongs
to the peptidase M1 family. IRAP (mouse 966aa, rat 1025 aa; human 1025
aa, chromosome 5q14.2-q15) release an n-terminal amino acid, cleave
before cysteine, leucine as well as other amino acids. IRAP, a
zinc-containing metalloprotein, degrade peptide hormone such as
oxytocin, vasopressin, and angiotensin III, inactivate Met-enkephalin
and dynorphin. It is a type 2 membrane protein and also secreted due to
proteolytic processing. IRAP is glycosylated and alternatively spliced
to at least 3 isoform (1-15 aa missing in isoform 2 and 1-20 missing in
isoform 3). The N-terminus (1-110 aa) is located in the cytoplasm,
followed by TM domain (111-131 aa) and the C-terminus (132-1025 aa) is
extracellualr. The secreted form is cleaved at 154-155 aa (processed
secreted form 155-1025 aa). IRAP is highly expressed in placenta, heart,
kidney, and small intestine. In brain, only the membrane form is found.
The brain form is found to be 140 kDa due to differential glycosylation.
TANK2 has also been shown to reside in the
low-density microsomes and associate with the
adapter protein, Grb14. The N-terminal 110-aa of Grb14 and 10-19
ANK-repeats of TANK2 mediate this interaction.
GRB14 (mouse/rat 538 aa, human 540 aa, chromosome 2) is a member
of GRB7 (Growth receptor bound proteins) family that includes Grb7, and
Grb10. Grb family is characterized by the presence of a conserved, short
non-catalytic SH2 domain (Src homology region 2) that binds to peptide
sequences containing phopshotyrosine. Many intracellular targets of
receptor tyrosine kinases contain 1 or more SH2 domains. GRB14 is widely
distributed in many tissues with an abundance in testis, ovary, heart,
liver, skeletal muscle, kidney, and pancreas. TANKs may play a role
vesicle trafficking and in cytoplasmic signal transduction pathways via
the Grg14.
Recently a novel
TANK1-binding protein termed TAB182
(tankyrase-binding protein of 182 kDa), which binds to the ANK
domain of TANK1 and TANK2 has been identified. TAB182 (human 1729 aa,
predicted size 182 kDa, actual size ~200 kDa) is expressed in heart,
lung, liver, kidney, pancreas, testing, ovary etc. TAB182 localizes to
nucleus and to the cytoplasm, where it co localizes with cortical actin
network. It serves as an acceptor of poly(ADP-ribosyl)ation by TANK1.
TANK1 is suggested to act as scaffold for large molecular mass complexes
made up of multiple binding proteins.
|
Items
|
Antigen
peptide
location
|
Ab
Host
|
*Expected
Ab Cross-
reactivity
|
Antisera
Cat #
(100 ul)
|
Aff.
Pure IgG
Cat #
(100 ug)
|
* Control Peptide
Cat#
(100 ug)
|
|
TANK-1/TNKS-1
(Ab #1)
|
h, 21-aa
~CT
|
Rb
|
h, m
|
TANK11-S
|
TANK11-A
|
TANK11-P
|
|
TANK-1/TNKS-1
ab # 2
|
h, 17-aa ~NT
|
Rb
|
h (m, r?)
|
TANK12-S
|
TANK12-A
|
TANK12-P
|
|
TANK-1/TNKS-1
ab # 3
|
TANk protein
human
|
m, mono
|
H (m, r?)
|
|
TANK13-M
|
|
|
TANK2
|
h, 14-aa ~I
|
Rb
|
h (m, r?)
|
TANK21-S
|
TANK21-A
|
TANK21-P
|
|
IRAP
|
r, 17-aa ~EC
|
Rb
|
r, m, h
|
IRAP11-S
|
IRAP11-A
|
IRAP11-P
|
|
Grb14 |
r 16-aa ~CT
|
Rb |
GRB14-S |
GRB14-S
|
GRB14-A
|
GRB14-P
|
|
TAB182 |
h/m 15-aa ~CT
|
Rb |
r, m, h |
TAB182-S
|
TAB182-A
|
TAB182-P
|
|
Poly ADP ribose |
ADP-ribose
|
m, mono
|
all species
|
|
ADPR12-M |
|
|
Poly ADP ribose
|
Poly
ADP ribosylated proteins for Western blot,
Cat #
ADPR11-C (100ul) |
|
Control Rabbit IgG
|
For use in ELISA, Western,
Immunohisto., Cat # 20009-1 (1 mg)
|
List of publications using ADI's
Telomerase/Est2:
Telomerase/Est2 Zhang P 2003 FASEB J Feb
2003 in press TERT suppresses apoptotis at a premitochondrial step by a
mechanism requiring reverse transcriptase activity and 14-3-3 protein
binding ability,
IHC used 1:3K; also AIF/mab.
Telomerase/Est2 Hiyama E 2003 Cancer Lett.
in press Telomerase as tumor marker IHC bronchial biopsy sample obtained
from a patient with squamous cell carcinoma of the lung/EST21-A.
TRF2 Oh H 2003 Telomere attrition and Chk2
activation in human heart failure PNAS, Apr 2003; 100: 5378 - 5383. WB
IHC rat.
Telomerase/Est2 Hiyama, E et al 2001
Neoplasia, 2001, 3, 17-26 Immunohistochemical detection of telomerase
(hTERT) protein in human cancer tissues and a subset of cells in normal
tissues paraffin section, est21-c.
Telomerase/Est2 Xiang Hua et al 2000 BBRC
278, 503-510, hTERT Can Function with Rabbit Telomerase RNA: Regulation
of Gene Expression and Attenuation of Apoptosis.
Notes: Antibodies usage is indicated in the following techniques:
WB=Western Blot ; IHC-Immunohistochmistry; IP=Immunoprecipition;
Flow=Flow cytometry; Rev. 30626
m=mouse; r=rat; h=human; b=bovine; d=dog;ch=chicken; ~CT
or ~NT=near C or N-terminus.
EC=Extracellular; CP=Cytoplasmic
domain; I=Internal;
* Expected antibody crossreactivity
information is mostly based upon high (>70%) sequence conservation of
antigenic/control peptides in various species. When antibody
crossreactivity has actually been experimentally confirmed in various
species, it will be mentioned in the appropriate data sheets.
"Neat Antisera or antisera" are the
unpurified antiserum and it is suitable for ELISA and Western.
"Affinity pure" IgG may be more suitable
for immunohistochemical (IHC) applications and to reduce background in
most immunological applications including ELISA and Western.
"Control peptides" can not be used for
Western as they are very short peptides. They are intended for ELISA or
antibody blocking studies to establish antibody specificity.
Western blot +ve protein controls, where available, are semi-pure, pure
or recombinant proteins that are formulated in SDS-PAGE sample buffer.
They are recommended to be used for Western (load 10 ul/lane) for
visualization with antibodies.
|